top of page

Este site foi desenvolvido com o criador de sites

. Crie seu site hoje.Começar

Home
Project members
News
Job openings
More

Use tab to navigate through the menu items.

Alexandre Charneca

School of Pharmacy (FFUL), ULisboa, Portugal (MSc student)

Alexandre Charneca

Proteolysis-targeting chimeric technology for the development of mutant p53-based anticancer drugs

Reference: 2023.18068.ICDT; DOI: https://doi.org/10.54499/2023.18068.ICDT.

© 2025 by Medicinal Organic Chemistry group. Powered and secured by Wix

bottom of page